Myrte B. Breukink - Concepedia

Author

Myrte B. Breukink

Radboud University Nijmegen

Also Known As

Myrte B Breukink, Myrte B. Breukink, Myrte Breukink

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Radboud University Medical Center Leiden University Medical Center University Hospital Cologne University of Amsterdam

About

Myrte B. Breukink is an author at Radboud University Nijmegen specializing in ophthalmology, genetics, and age-related diseases.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	133
2	Public Health	1	1	133
3	Pathology	1	1	133
4	Genetic Epidemiology	1	1	133
5	Genetics	1	1	133

Myrte B. Breukink

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy Elon H. C. van Dijk, Sascha Fauser, Myrte B. Breukink, Ophthalmology	2018	324
OCT Angiography Compared to Fluorescein and Indocyanine Green Angiography in Chronic Central Serous Chorioretinopathy Michel M. Teussink, Myrte B. Breukink, Mark J. J. P. van Grinsven, Investigative Ophthalmology & Visual Science	2015	155
Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life Myrte B. Breukink, Alexander J.M. Dingemans, Anneke I. den Hollander, Clinical ophthalmology	2016	152
Chronic Central Serous Chorioretinopathy Is Associated with Genetic Variants Implicated in Age-Related Macular Degeneration Eiko K. de Jong, Myrte B. Breukink, Rosa L. Schellevis, Ophthalmology Genetic VariantsOcular DiseaseOphthalmologyGenetic DisorderGenetics	2014	133
Association of a Haplotype in the <i>NR3C2</i> Gene, Encoding the Mineralocorticoid Receptor, With Chronic Central Serous Chorioretinopathy Elon H. C. van Dijk, Rosa L. Schellevis, Maaike G.J.M. van Bergen, JAMA Ophthalmology	2017	74
Role of the Complement System in Chronic Central Serous Chorioretinopathy Rosa L. Schellevis, Elon H. C. van Dijk, Myrte B. Breukink, JAMA Ophthalmology	2018	67
Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3 Thomas J. van Rijssen, Elon H. C. van Dijk, Paula Scholz, American Journal of Ophthalmology Subthreshold Micropulse LaserRadiologyHalf-dose Photodynamic TherapyOphthalmology	2019	59
Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial Myrte B. Breukink, Susan M. Downes, Giuseppe Querques, Trials	2015	49
Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial Thomas J. van Rijssen, Elon H. C. van Dijk, Paula Scholz, American Journal of Ophthalmology	2020	49
Genomic Copy Number Variations of the Complement Component<i>C4B</i>Gene Are Associated With Chronic Central Serous Chorioretinopathy Myrte B. Breukink, Rosa L. Schellevis, Camiel J. F. Boon, Investigative Ophthalmology & Visual Science	2015	45

Page 1